Quia Pharma AB (publ) (STO:QUIA)
0.0035
+0.0001 (2.94%)
Aug 13, 2025, 3:25 PM CET
Heartland Financial USA Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0 | 0.1 | 2.57 | 5.34 | 8.59 | Upgrade |
Cash & Short-Term Investments | 0 | 0.1 | 2.57 | 5.34 | 8.59 | Upgrade |
Cash Growth | -98.02% | -96.06% | -51.96% | -37.81% | 88.91% | Upgrade |
Accounts Receivable | - | - | 0.22 | 0.22 | 0.01 | Upgrade |
Other Receivables | 0.77 | 0.79 | 0.73 | 0.68 | 0.77 | Upgrade |
Receivables | 0.77 | 0.79 | 0.95 | 0.9 | 0.77 | Upgrade |
Prepaid Expenses | 0.1 | 0.27 | 0.25 | 0.05 | 0.1 | Upgrade |
Other Current Assets | 0.17 | 0.6 | - | - | -0 | Upgrade |
Total Current Assets | 1.05 | 1.76 | 3.76 | 6.29 | 9.46 | Upgrade |
Property, Plant & Equipment | 0.06 | 0.27 | 0.52 | 0.78 | 0.94 | Upgrade |
Other Intangible Assets | 11.7 | 32.66 | 12.28 | 10.92 | 10.14 | Upgrade |
Long-Term Deferred Charges | 5.49 | 7.27 | 6.88 | 5.78 | - | Upgrade |
Total Assets | 18.3 | 41.96 | 23.44 | 23.76 | 20.54 | Upgrade |
Accounts Payable | 3.77 | 3.18 | 1.33 | 2.84 | 1.05 | Upgrade |
Accrued Expenses | 0.99 | 1.25 | 3.07 | 1.55 | 2.47 | Upgrade |
Current Portion of Long-Term Debt | 0.5 | 20.61 | 0.32 | 0.78 | 4.6 | Upgrade |
Current Income Taxes Payable | 0.24 | 0.3 | 0.19 | 0.23 | 0.33 | Upgrade |
Other Current Liabilities | 0.9 | 1.36 | 0.91 | 1.32 | 10.87 | Upgrade |
Total Current Liabilities | 6.4 | 26.71 | 5.82 | 6.72 | 19.32 | Upgrade |
Long-Term Debt | - | - | 15.21 | 17.02 | 1.15 | Upgrade |
Total Liabilities | 6.4 | 26.71 | 21.03 | 23.74 | 20.47 | Upgrade |
Common Stock | 23.78 | 23.31 | 23.69 | 42.67 | 49.79 | Upgrade |
Additional Paid-In Capital | 13.33 | 12.63 | 22.52 | 29.43 | 26.54 | Upgrade |
Retained Earnings | -25.21 | -20.69 | -43.81 | -72.08 | -76.26 | Upgrade |
Comprehensive Income & Other | - | - | - | - | -0 | Upgrade |
Shareholders' Equity | 11.9 | 15.25 | 2.41 | 0.02 | 0.07 | Upgrade |
Total Liabilities & Equity | 18.3 | 41.96 | 23.44 | 23.76 | 20.54 | Upgrade |
Total Debt | 0.5 | 20.61 | 15.52 | 17.8 | 5.75 | Upgrade |
Net Cash (Debt) | -0.5 | -20.51 | -12.96 | -12.46 | 2.84 | Upgrade |
Net Cash Per Share | -0.00 | -0.28 | -7.31 | -19.88 | 6.87 | Upgrade |
Filing Date Shares Outstanding | 1,683 | 74.5 | 2.37 | 0.85 | 0.61 | Upgrade |
Total Common Shares Outstanding | 1,683 | 74.5 | 2.37 | 0.85 | 0.55 | Upgrade |
Working Capital | -5.35 | -24.94 | -2.06 | -0.43 | -9.86 | Upgrade |
Book Value Per Share | 0.01 | 0.20 | 1.02 | 0.03 | 0.13 | Upgrade |
Tangible Book Value | 0.2 | -17.41 | -9.86 | -10.89 | -10.07 | Upgrade |
Tangible Book Value Per Share | 0.00 | -0.23 | -4.16 | -12.76 | -18.21 | Upgrade |
Machinery | 1.27 | 1.27 | 1.27 | 1.27 | 1.19 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.